<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38139298</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>24</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>14</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Inflammatory and Prothrombotic Biomarkers Contribute to the Persistence of Sequelae in Recovered COVID-19 Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">17468</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms242417468</ELocationID><Abstract><AbstractText>The presence of long COVID (LC) following SARS-CoV-2 infection is a common condition that affects the quality of life of patients and represents a diagnostic challenge due to the diversity of symptoms that may coexist. We still do not have accurate information regarding the pathophysiological pathways that generate the presence of LC, and so it is important to know the inflammatory and immunothrombotic biomarker profiles and their implications in order to characterize risk subgroups and establish early therapeutic strategies. We performed the determination of inflammatory and immunothrombotic biomarkers in volunteers with previous diagnoses of SARS-CoV-2. The inflammatory biomarkers were analyzed in plasma by flow cytometry, and we analyzed the von Willebrand factor (vWF) in the plasma samples using ELISA. The clinical variables and the presence or absence of long COVID symptoms were then analyzed. IL-6, sCD40L, p-Selectin, PSGL-1, PAI-1, tPA, D-Dimer, TF, and Factor IX levels were elevated in the groups with LC, especially in the subgroup of patients with metabolic syndrome (MetS). VWF levels were found to be increased in patients with sequelae and MetS. Our results confirmed the persistence of an active immunothrombotic state, and so it is important to identify the population at risk in order to provide adequate clinical follow-up.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Garcia-Larragoiti</LastName><ForeName>Nallely</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-9333-9200</Identifier><AffiliationInfo><Affiliation>Divisi&#xf3;n de Estudios de Posgrado, Facultad de Ciencias M&#xe9;dicas y Biol&#xf3;gicas "Dr. Ignacio Ch&#xe1;vez", Universidad Michoacana de San Nicol&#xe1;s de Hidalgo, Morelia 58060, Michoac&#xe1;n, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cano-Mendez</LastName><ForeName>Alan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Divisi&#xf3;n de Estudios de Posgrado, Facultad de Ciencias M&#xe9;dicas y Biol&#xf3;gicas "Dr. Ignacio Ch&#xe1;vez", Universidad Michoacana de San Nicol&#xe1;s de Hidalgo, Morelia 58060, Michoac&#xe1;n, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro Multidisciplinario de Estudios en Biotecnolog&#xed;a, Facultad de Medicina Veterinaria y Zootecnia, Universidad Michoacana de San Nicol&#xe1;s de Hidalgo, Morelia 58060, Michoac&#xe1;n, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jimenez-Vega</LastName><ForeName>Yeny</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Divisi&#xf3;n de Estudios de Posgrado, Facultad de Ciencias M&#xe9;dicas y Biol&#xf3;gicas "Dr. Ignacio Ch&#xe1;vez", Universidad Michoacana de San Nicol&#xe1;s de Hidalgo, Morelia 58060, Michoac&#xe1;n, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trujillo</LastName><ForeName>Mercedes</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Divisi&#xf3;n de Estudios de Posgrado, Facultad de Ciencias M&#xe9;dicas y Biol&#xf3;gicas "Dr. Ignacio Ch&#xe1;vez", Universidad Michoacana de San Nicol&#xe1;s de Hidalgo, Morelia 58060, Michoac&#xe1;n, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guzman-Cancino</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Divisi&#xf3;n de Estudios de Posgrado, Facultad de Ciencias M&#xe9;dicas y Biol&#xf3;gicas "Dr. Ignacio Ch&#xe1;vez", Universidad Michoacana de San Nicol&#xe1;s de Hidalgo, Morelia 58060, Michoac&#xe1;n, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ambriz-Murillo</LastName><ForeName>Yesenia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Divisi&#xf3;n de Estudios de Posgrado, Facultad de Ciencias M&#xe9;dicas y Biol&#xf3;gicas "Dr. Ignacio Ch&#xe1;vez", Universidad Michoacana de San Nicol&#xe1;s de Hidalgo, Morelia 58060, Michoac&#xe1;n, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Regional de Morelia ISSSTE, Morelia 58300, Michoac&#xe1;n, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viveros-Sandoval</LastName><ForeName>Martha Eva</ForeName><Initials>ME</Initials><Identifier Source="ORCID">0000-0002-2801-643X</Identifier><AffiliationInfo><Affiliation>Divisi&#xf3;n de Estudios de Posgrado, Facultad de Ciencias M&#xe9;dicas y Biol&#xf3;gicas "Dr. Ignacio Ch&#xe1;vez", Universidad Michoacana de San Nicol&#xe1;s de Hidalgo, Morelia 58060, Michoac&#xe1;n, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>320085 CONAHCYT Frontier Science program</GrantID><Agency>Consejo Nacional de Humanidades, Ciencias y Tecnolog&#xed;as</Agency><Country/></Grant><Grant><GrantID>UMNSH-CIC 2022</GrantID><Agency>Universidad Michoacana de San Nicol&#xe1;s de Hidalgo</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014841">von Willebrand Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014841" MajorTopicYN="N">von Willebrand Factor</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024821" MajorTopicYN="Y">Metabolic Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">immunothrombosis</Keyword><Keyword MajorTopicYN="N">inflammation markers</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">metabolic syndrome</Keyword><Keyword MajorTopicYN="N">prothrombotic biomarkers</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>23</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>23</Day><Hour>1</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38139298</ArticleId><ArticleId IdType="pmc">PMC10744310</ArticleId><ArticleId IdType="doi">10.3390/ijms242417468</ArticleId><ArticleId IdType="pii">ijms242417468</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hu B., Guo H., Zhou P., Shi Z.L. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 2021;19:141&#x2013;154. doi: 10.1038/s41579-020-00459-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00459-7</ArticleId><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B., Julg B., Mohandas S., Bradfute S.B., RECOVER Mechanistic Pathways Task Force Viral persistence, reactivation, and mechanisms of long COVID. eLife. 2023;12:e86015. doi: 10.7554/eLife.86015.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86015</ArticleId><ArticleId IdType="pmc">PMC10159620</ArticleId><ArticleId IdType="pubmed">37140960</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai C.C., Hsu C.K., Yen M.Y., Lee P.I., Ko W.C., Hsueh P.R. Long COVID: An inevitable sequela of SARS-CoV-2 infection. J. Microbiol. Immunol. Infect. 2023;56:1&#x2013;9. doi: 10.1016/j.jmii.2022.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2022.10.003</ArticleId><ArticleId IdType="pmc">PMC9576029</ArticleId><ArticleId IdType="pubmed">36283919</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M.L., Patel S.K., Juno J.A., Burrell L.M., Kent S.J., Dore G.J., et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 2022;23:210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Pintos-Pascual I., Moreno-Torres V., Ib&#xe1;nez-Est&#xe9;llez F., Corrales-Rodriguez P., Trevi&#xf1;o A., Corpas M., Corral O., Soriano V., de Mendoza C. Is SARS-CoV-2 the only cause of long-COVID? AIDS Rev. 2022;24:183&#x2013;196. doi: 10.24875/AIDSRev.22000025.</Citation><ArticleIdList><ArticleId IdType="doi">10.24875/AIDSRev.22000025</ArticleId><ArticleId IdType="pubmed">36427058</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C. Long COVID: Current definition. Infection. 2022;50:285&#x2013;286. doi: 10.1007/s15010-021-01696-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01696-5</ArticleId><ArticleId IdType="pmc">PMC8438555</ArticleId><ArticleId IdType="pubmed">34519974</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera Martimbianco A.L., Pacheco R.L., Bagattini &#xc2;.M., Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: A systematic review. Int. J. Clin. Pract. 2021;75:e14357. doi: 10.1111/ijcp.14357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14357</ArticleId><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Healey Q., Sheikh A., Daines L., Vasileiou E. Symptoms and signs of long COVID: A rapid review and meta-analysis. J. Glob. Health. 2022;12:05014. doi: 10.7189/jogh.12.05014.</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.12.05014</ArticleId><ArticleId IdType="pmc">PMC9125197</ArticleId><ArticleId IdType="pubmed">35596571</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubey S., Biswas P., Ghosh R., Chatterjee S., Dubey M.J., Chatterjee S., Lahiri D., Lavie C.J. Psychosocial impact of COVID-19. Diabetes Metab. Syndr. 2020;14:779&#x2013;788. doi: 10.1016/j.dsx.2020.05.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.05.035</ArticleId><ArticleId IdType="pmc">PMC7255207</ArticleId><ArticleId IdType="pubmed">32526627</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbouzas A.E., Malli F., Daniil Z., Gourgoulianis K. Long-Term Impact of COVID-19 Pandemic in Sleep Quality and Lifestyle in Young Adults. Int. J. Environ. Res. Public Health. 2022;19:12333. doi: 10.3390/ijerph191912333.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191912333</ArticleId><ArticleId IdType="pmc">PMC9564795</ArticleId><ArticleId IdType="pubmed">36231637</ArticleId></ArticleIdList></Reference><Reference><Citation>Astin R., Banerjee A., Baker M.R., Dani M., Ford E., Hull J.H., Lim P.B., McNarry M., Morten K., O&#x2019;Sullivan O., et al. Long COVID: Mechanisms, risk factors and recovery. Exp. Physiol. 2023;108:12&#x2013;27. doi: 10.1113/EP090802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP090802</ArticleId><ArticleId IdType="pmc">PMC10103775</ArticleId><ArticleId IdType="pubmed">36412084</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H.P., Sun Y.L., Wang Y.F., Yazici D., Azkur D., Ogulur I., Azkur A.K., Yang Z.W., Chen X.X., Zhang A.Z., et al. Recent developments in the immunopathology of COVID-19. Allergy. 2023;78:369&#x2013;388. doi: 10.1111/all.15593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15593</ArticleId><ArticleId IdType="pmc">PMC10108124</ArticleId><ArticleId IdType="pubmed">36420736</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann D.M., Whettlock E.M., Liu S., Arachchillage D.J., Boyton R.J. The immunology of long COVID. Nat. Rev. Immunol. 2023;23:618&#x2013;634. doi: 10.1038/s41577-023-00904-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-023-00904-7</ArticleId><ArticleId IdType="pubmed">37433988</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S., Khan M.A., Putrino D., Woodcock A., Kell D.B., Pretorius E. Long COVID: Pathophysiological factors and abnormalities of coagulation. Trends Endocrinol. Metab. TEM. 2023;34:321&#x2013;344. doi: 10.1016/j.tem.2023.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2023.03.002</ArticleId><ArticleId IdType="pmc">PMC10113134</ArticleId><ArticleId IdType="pubmed">37080828</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M., Blish C.A., Sallusto F., Iwasaki A. The immunology and immunopathology of COVID-19. Science. 2022;375:1122&#x2013;1127. doi: 10.1126/science.abm8108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Sette A., Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell. 2021;184:861&#x2013;880. doi: 10.1016/j.cell.2021.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.01.007</ArticleId><ArticleId IdType="pmc">PMC7803150</ArticleId><ArticleId IdType="pubmed">33497610</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolai L., Kaiser R., Stark K. Thromboinflammation in long COVID-the elusive key to postinfection sequelae? J. Thromb. Haemost. JTH. 2023;21:2020&#x2013;2031. doi: 10.1016/j.jtha.2023.04.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtha.2023.04.039</ArticleId><ArticleId IdType="pmc">PMC10174338</ArticleId><ArticleId IdType="pubmed">37178769</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins-Gon&#xe7;alves R., Hottz E.D., Bozza P.T. Acute to post-acute COVID-19 thromboinflammation persistence: Mechanisms and potential consequences. Curr. Res. Immunol. 2023;4:100058. doi: 10.1016/j.crimmu.2023.100058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.crimmu.2023.100058</ArticleId><ArticleId IdType="pmc">PMC10083200</ArticleId><ArticleId IdType="pubmed">37064788</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing H., Wu X., Xiang M., Liu L., Novakovic V.A., Shi J. Pathophysiological mechanisms of thrombosis in acute and long COVID-19. Front. Immunol. 2022;13:992384. doi: 10.3389/fimmu.2022.992384.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.992384</ArticleId><ArticleId IdType="pmc">PMC9709252</ArticleId><ArticleId IdType="pubmed">36466841</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H., Ward S.E., Townsend L., Karampini E., Elliott S., Conlon N., Dunne J., Kiersey R., Naughton A., Gardiner M., et al. Sustained VWF-ADAMTS-13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunction. J. Thromb. Haemost. JTH. 2022;20:2429&#x2013;2438. doi: 10.1111/jth.15830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15830</ArticleId><ArticleId IdType="pmc">PMC9349977</ArticleId><ArticleId IdType="pubmed">35875995</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanini G., Selleri V., Roncati L., Coppi F., Nasi M., Farinetti A., Manenti A., Pinti M., Mattioli A.V. Vascular &#x201c;Long COVID&#x201d;: A New Vessel Disease? Angiology. 2024;75:8&#x2013;14. doi: 10.1177/00033197231153204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00033197231153204</ArticleId><ArticleId IdType="pmc">PMC9895315</ArticleId><ArticleId IdType="pubmed">36652923</ArticleId></ArticleIdList></Reference><Reference><Citation>Bornstein S.R., Cozma D., Kamel M., Hamad M., Mohammad M.G., Khan N.A., Saber M.M., Semreen M.H., Steenblock C. Long-COVID, Metabolic and Endocrine Disease. Horm. Metab. Res. 2022;54:562&#x2013;566. doi: 10.1055/a-1878-9307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1878-9307</ArticleId><ArticleId IdType="pmc">PMC9363148</ArticleId><ArticleId IdType="pubmed">35724687</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizvi A.A., Kathuria A., Al Mahmeed W., Al-Rasadi K., Al-Alawi K., Banach M., Banerjee Y., Ceriello A., Cesur M., Cosentino F., et al. Post-COVID syndrome, inflammation, and diabetes. J. Diabetes Its Complicat. 2022;36:108336. doi: 10.1016/j.jdiacomp.2022.108336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdiacomp.2022.108336</ArticleId><ArticleId IdType="pmc">PMC9534783</ArticleId><ArticleId IdType="pubmed">36228563</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruilope L.M., Nunes Filho A.C.B., Nadruz W., Jr., Rodr&#xed;guez Rosales F.F., Verdejo-Paris J. Obesity and hypertension in Latin America: Current perspectives. Hipertens. Y Riesgo Vasc. 2018;35:70&#x2013;76. doi: 10.1016/j.hipert.2017.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hipert.2017.12.004</ArticleId><ArticleId IdType="pubmed">29361428</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Castaneda S., Garc&#xed;a-Larragoiti N., Cano-Mendez A., Blancas-Ayala K., Damian-V&#xe1;zquez G., Perez-Medina A.I., Chora-Hern&#xe1;ndez L.D., Arean-Mart&#xed;nez C., Viveros-Sandoval M.E. Inflammatory and Prothrombotic Biomarkers Associated With the Severity of COVID-19 Infection. Clin. Appl. Thromb. Hemost. 2021;27:1076029621999099. doi: 10.1177/1076029621999099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1076029621999099</ArticleId><ArticleId IdType="pmc">PMC8040552</ArticleId><ArticleId IdType="pubmed">33835872</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin K., Peluso M.J., Luo X., Thomas R., Shin M.G., Neidleman J., Andrew A., Young K., Ma T., Hoh R., et al. Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2. bioRxiv. 2023;4:527892. doi: 10.1101/2023.02.09.527892.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.02.09.527892</ArticleId><ArticleId IdType="pmc">PMC10834368</ArticleId><ArticleId IdType="pubmed">38212464</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann A., Prosch H., Zehetmayer S., Gysan M.R., Bernitzky D., Vonbank K., Idzko M., Gompelmann D. Impact of persistent D-dimer elevation following recovery from COVID-19. PLoS ONE. 2021;16:e0258351. doi: 10.1371/journal.pone.0258351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0258351</ArticleId><ArticleId IdType="pmc">PMC8553152</ArticleId><ArticleId IdType="pubmed">34710097</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Z., Zhong L., Zhu S., Wang Y., Zheng J., Wang S., Zhang J., Huang R. The P-selectin and PSGL-1 axis accelerates atherosclerosis via activation of dendritic cells by the TLR4 signaling pathway. Cell Death Dis. 2019;10:507. doi: 10.1038/s41419-019-1736-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1736-5</ArticleId><ArticleId IdType="pmc">PMC6602970</ArticleId><ArticleId IdType="pubmed">31263109</ArticleId></ArticleIdList></Reference><Reference><Citation>Merten M., Thiagarajan P. P-selectin in arterial thrombosis. Z Kardiol. 2004;93:855&#x2013;863. doi: 10.1007/s00392-004-0146-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-004-0146-5</ArticleId><ArticleId IdType="pubmed">15568145</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y., Warnock M., Harbaugh A., Yalavarthi S., Gockman K., Zuo M., Madison J.A., Knight J.S., Kanthi Y., Lawrence D.A. Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients. Sci. Rep. 2021;11:1580. doi: 10.1038/s41598-020-80010-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-80010-z</ArticleId><ArticleId IdType="pmc">PMC7810990</ArticleId><ArticleId IdType="pubmed">33452298</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorog D.A., Storey R.F., Gurbel P.A., Tantry U.S., Berger J.S., Chan M.Y., Duerschmied D., Smyth S.S., Parker W.A.E., Ajjan R.A., et al. Current and novel biomarkers of thrombotic risk in COVID-19: A Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium. Nat. Rev. Cardiol. 2022;19:475&#x2013;495. doi: 10.1038/s41569-021-00665-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-021-00665-7</ArticleId><ArticleId IdType="pmc">PMC8757397</ArticleId><ArticleId IdType="pubmed">35027697</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>